Literature DB >> 10683243

Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats.

T Pawelczyk1, M Sakowicz, M Szczepanska-Konkel, S Angielski.   

Abstract

Adenosine has been implicated as an important endogenous regulator of various tissue functions. In diabetes, the responsiveness of several tissues to adenosine is altered. The aim of this study was to investigate the activities of enzymes metabolizing adenosine in tissues of diabetic rats. The cytosolic activity (V(max)) of adenosine kinase (AK) was decreased by 50% in the kidney and by 40% in the heart and liver of diabetic rats. A decrease in the V(max) of AK in diabetic tissues was not associated with a change in the K(m) for adenosine. Evaluation of AK gene transcript status showed significantly lower levels of AK mRNA in diabetic tissues as compared to normal tissues. In diabetic kidneys, the level of AK gene transcript was lowered by 50% on first day after streptozotocin administration, and these reduced levels were sustained declined during the next 10 days. Smaller changes in AK gene transcript levels were observed in the heart and liver than in the kidney. The cytosolic activities of 5'-nucleotidase, AMP deaminase, and adenosine deaminase were unchanged in kidney, heart, and liver of diabetic rats. These results suggest that the turnover of the AMP-adenosine metabolic cycle might be impaired in diabetic tissues due to the reduced activity of adenosine kinase. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683243     DOI: 10.1006/abbi.1999.1548

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

1.  Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters.

Authors:  Marzena Podgorska; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

2.  The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats.

Authors:  Eldo V Kuzhikandathil; Leslie Clark; Ying Li
Journal:  J Biol Chem       Date:  2011-07-29       Impact factor: 5.157

3.  Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat.

Authors:  Tadeusz Pawelczyk; Marzena Grden; Robert Rzepko; Monika Sakowicz; Andrzej Szutowicz
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes.

Authors:  Monika Sakowicz-Burkiewicz; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

Review 5.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

6.  Insulin restores expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats.

Authors:  Monika Sakowicz; Tadeusz Pawelczyk
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

7.  Autophagy contributes to retardation of cardiac growth in diabetic rats.

Authors:  Youngjeon Lee; Yunkyung Hong; Sang-Rae Lee; Kyu-Tae Chang; Yonggeun Hong
Journal:  Lab Anim Res       Date:  2012-06-26

Review 8.  Adenosine kinase: An epigenetic modulator in development and disease.

Authors:  Madhuvika Murugan; Denise Fedele; David Millner; Enmar Alharfoush; Geetasravya Vegunta; Detlev Boison
Journal:  Neurochem Int       Date:  2021-05-05       Impact factor: 4.297

9.  Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system.

Authors:  Joana Vindeirinho; Gabriel N Costa; Mariana B Correia; Cláudia Cavadas; Paulo F Santos
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  The Adenosinergic System in Diabetic Retinopathy.

Authors:  J Vindeirinho; A R Santiago; C Cavadas; A F Ambrósio; P F Santos
Journal:  J Diabetes Res       Date:  2016-02-29       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.